Contact this trialFirst, we need to learn more about you.
Gasotransmitter
Inhaled Carbon Monoxide for Acute Respiratory Distress Syndrome (ARDS)
Recruiting0 awardsPhase 2
Brooklyn, New York
This trial will study inhaled carbon monoxide (iCO) as a potential treatment for ARDS, testing its safety, tolerability, and efficacy. The trial will be conducted at 7 tertiary care medical centers.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service